Production of Molybdenum-99 by Heterogeneous and Homogeneous Uranium Fueled Reactors
36th Annual CNS-CNA Student Conference - 2012 June 12

Presented at:
36th Annual CNS-CNA Student Conference
2012 June 12
Saskatoon, Canada
Session Title:
CNS/CNA Student Conference 2012

George Carlin (Master's Student )
Hugues Bonin (Royal Military College of Canada )


The use of radioisotopes for various procedures in the health care industry has become one of the most important practices in medicine. At the forefront of the medical isotope list is molybdenum-99 and its daughter isotope technetium-99m, which encompass over 80% of radiopharmaceutical procedures. Fission of uranium-235 to produce molybdenum-99 is the most widely used method for producing this radioisotope. The heterogeneous reactor and the aqueous homogeneous reactor are looked at here with emphasis on the use of low enriched uranium as the fuel source. Methods of technetium-99m generation and its medical use are also reviewed.

Individual Conference-Paper Copies (Electronic Where Available):

  • For CNS members, the first 5 copies per calendar year are free, and additional copies are $10 each.
  • For non-members, the price is $25 for the first Conference-paper copy in a request, and $10 each for additional copies of papers in the same conference and in the same request.
  • Contact the CNS office to order reprints.